Drug intelligence / Profile preview

金银花露

Development stage: Unknown
Lead developer: Hubei Wushi Pharmaceutical
Administration: Oral

Overview

金银花露 (Honeysuckle Dew) is a traditional Chinese medicine (TCM) oral liquid formulation developed and marketed by Hubei Wushi Pharmaceutical. It is an over-the-counter (OTC) product prepared through the distillation of honeysuckle flowers (*Lonicera japonica*). In TCM practice, it is primarily utilized for its heat-clearing and detoxifying properties, commonly indicated for the relief of heatstroke, thirst, and febrile conditions. Hubei Wushi Pharmaceutical employs patented preparation methods to enhance the yield and preserve the medicinal efficacy of the active components. The product is widely available in the Chinese market as an approved pharmaceutical for pediatric and adult use during summer months or for heat-related ailments.

Brand names: 金银花露
Other names: Honeysuckle DewHoneysuckle Flower DistillateJinyinhua Lu

Beyond the preview

Go deeper on 金银花露.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 金银花露.

Explore the full profile